Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liprotamase in Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
NCT02734810Phase 3Completed
- Sponsor
- Anthera Pharmaceuticals, Inc.
- Start
- Jun 2016
- Primary completion
- Dec 2016
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of liprotamase in exocrine pancreatic insufficiency (EPI), sponsored by Anthera Pharmaceuticals, Inc.. Started Jun 2016; status: completed.
02
Drugs
liprotamase
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT02734810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02734810.